GamaMabs Pharma is a clinical-stage immuno-oncology company developing optimized therapeutic antibodies for the treatment of cancer.

GamaMabs’ lead project is the monoclonal antibody (mAb) GM102 which targets Anti-Müllerian Human Receptor II (AMHRII), an unaddressed specific target in gynecological cancers.

The company develops low-fucose EMABling® antibodies with increased tumor cell killing properties through the activation of immune system cells. 


acheter viagra au quebec
combien coute le viagra en pharmacie en belgique
danger viagra coeur
cialis 5 mg le prix
prix pharmacie cialis 10mg
faut il ordonnance pour du viagra
le meilleur cialis